🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I/II, open-label, multi-center study conducted in patients ...
Status
Completed
Location
Winship Cancer Institute, Emory University
Start Date
2007-01
Trial ID
NCT00421525
Treatments Being Tested
Milatuzumab will be given subcutaneously at different dose levels once (dep...
Status
Completed
Location
Cedars Sinai Medical Center-Wallace Rheumatic Study Center
Start Date
2007-01
Trial ID
NCT01845740
Treatments Being Tested
A phase I dose escalation study of veltuzumab and milatuzumab in relapsed a...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2009-09
Trial ID
NCT00989586
This study will test different doses of anti-CD74 antibody in patients with...
Status
Completed
Location
Alabama at Birmingham Comprehensive Cancer Center
Start Date
2008-08
Trial ID
NCT00603668
Treatments Being Tested
Previous experience with antibody therapy in both NHL and CLL warrants furt...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2007-06
Trial ID
NCT00504972
Treatments Being Tested
This study is a Ph I trial to test the safety of the study drug, hLL1-DOX a...
Status
Terminated
Location
MD Anderson Orlando
Start Date
2010-07
Trial ID
NCT01101594
Treatments Being Tested
The primary objectives are to evaluate the safety and tolerability of hLL1-...
Status
Terminated
Location
Helen F. Graham Cancer Center
Start Date
2012-08
Trial ID
NCT01585688
Treatments Being Tested
The purpose of this study is to determine whether Milatuzumab is effective ...
Status
Unknown
Location
Kaplan Medical Center
Start Date
2009-04
Trial ID
NCT00868478
Treatments Being Tested
This study will assess the safety and tolerability of milatuzumab (IMMU-115...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2013-12
Trial ID
NCT01663766
Treatments Being Tested